Privacy Policy
Signals Blog

Contributors

Categories

Guest

Signals accepts guest blog posts on topics relevant to stem cells and regenerative medicine, as well as submissions for its Right Turn Friday feature. The opinions, accuracy, completeness and validity of any statements made in guest posts are the responsibility of the author only and not the editor of Signals or CCRM, publisher of Signals. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with the author. To reach the publisher, email info(at)CCRM.ca

Posts by: Guest


Bringing innovative cell and gene therapy products to Canadians

Author: Guest, 08/21/19

Siofradh McMahon is Senior Manager, Clinical Translation and Regulatory Affairs at CCRM. Síofradh works with academic and industry partners to advance promising products and technologies to commercialization. Having worked worldwide, Síofradh brings more than a decade of experience in pharmaceutical and biotech regulatory affairs and policy. She is an active member of the Alliance for […]

Business of Regenerative Medicine Conference 2019: The rundown

Author: Guest, 08/08/19

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization (OBIO) where he was involved in supporting health science companies gain access to private and public capital, providing strategic […]

Crowdfunding and the global marketplace for unproven stem cell interventions

Author: Guest, 07/15/19

Jeremy Snyder, PhD, is a Professor in the Faculty of Health Sciences at Simon Fraser University. Leigh Turner, PhD, is an Associate Professor in the Center for Bioethics, School of Public Health and College of Pharmacy at the University of Minnesota. You can find them on Twitter @jeremycsnyder and @LeighGTurner Direct-to-consumer (DTC) marketing of unproven […]

Got “sciart”?

Author: Guest, 07/12/19

Eleni Kanavas is the Acting Communications Specialist at CCRM. She has more than eight years of corporate communications experience working in the academic and health science fields. She graduated with an Honours BA in Journalism from the University of Toronto and an Ontario College Advanced Diploma in Journalism from Centennial College. Eleni previously worked at Sunnybrook Research […]

CCRM’s inaugural investor symposium: Recap and key takeaways

Author: Guest, 05/08/19

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization (OBIO) where he was involved in supporting health science companies gain access to private and public capital, providing strategic […]